Cached score snapshot

US.A · Agilent Technologies

110分制 56.4/110;5D動能v2 7/50;排序分 63.4/160

Ranking score 63.4/160
Main score 56.4/110
5D momentum v2 7/50
Rank #290
Setup grade F 34.6

Score breakdown

觀望

Medium twelvedata

Score and price trend

F 34.6 Technical A · Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 08-04 09-16 10-28 11-18 12-08 $132.02$165.63$199.24 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling calibration best · score 2.507 · anchors 120 +0.79% -1.80% / +2.90% 60% 0% Actual outcome pending · 0 / 3 bars observed
30D observation -0.57% -5.96% / +3.74% 42.5% 30% Actual outcome pending · 0 / 30 bars observed
Historical projection 10D n=160 +0.81% -1.19% / +2.71% 61.9% 4.4% Actual outcome pending · 0 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-08-04 → 2026-12-08 · 120 archived points · 2 Improving turn signal · 4 Deteriorating signal · 1 Exit review signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 63.4
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 56.4/110 (觀望)
5D momentum v2 7/50 (弱)
Score with momentum v2 63.4/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 172.0855
ma50 162.54
close 177.49
prevClose 175.96
avgVolume20 2166916
volumeRatio 1.06
changePercent 0.87

Metrics snapshot

close 177.49
volume 2292218
changePercent 0.87

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 56.4/110
Main rating 觀望
5D momentum v2 7/50
Score with momentum v2 63.4/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.6/5 · 良好

Dimension score 3.6/5
Dimension grade 良好

Sub-items

pbPoints 0.2
pePoints 0.2
epsPoints 0
roePoints 0.75
debtPoints 0.5
marginPoints 0.6
turnoverUsdM 406.8458
volumePoints 0.5
revenuePoints 0
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 11.6/20 · 較差

Dimension score 11.6/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 2.4
obvPoints 2.4
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.A
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 7.4/15 · 較差

Dimension score 7.4/15
Dimension grade 較差

Sub-items

vix

score 1.8

details

source twelvedata+fred
vixClose 18.39

trend

score 1.8

details

qqq

ma20 733.184
ma50 725.2622
name QQQ
close 721.24
points 0.4

spy

ma20 770.4115
ma50 767.5288
name SPY
close 769.66
points 1.4
source twelvedata+fred
atrPct 2.6368
atrPoints 3
cciPoints 0.8
vixPoints 1.8
marketTrendPoints 1.8

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 5
catalystCount 0
catalystPoints 2

風險管理 — 6.8/10 · 一般

Dimension score 6.8/10
Dimension grade 一般

Sub-items

position

score 1.6

details

atrPct 2.6368
turnoverUsdM 406.8458
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.A
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 168.13

strength_details

ma_score 1.5
atr_score 2
rsi_score 3
macd_score 1.5
volume_score 2
market_adjustment 1
risk_reward_ratio 1.3
stop_loss_percent 5.3
take_profit_price 189.1978
target_multiplier 1.9
technical_strength 1.98
take_profit_percent 6.6
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2515
stopLossPercent 5.2735
diversificationPoints 2

技術信號 — 22/30 · 良好

Dimension score 22/30
Dimension grade 良好

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 1.6
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 1.6
vcp_reason 波幅收縮(18.1%→5.4%);站上MA50;Ready=N;Confirm=N

vcp_metrics

up_days 5
vol_ref 2419750
down_days 4
vcp_ready false
above_ma50 true
avg_vol_10 2141540
avg_vol_20 2154995
avg_vol_30 2419750
range_pct_10 0.0536
range_pct_20 0.0889
range_pct_30 0.1809
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok false
up_expand_days 0
breakout_20d_ok false
vol_ratio_10_30 0.885
dist_to_20d_high 0.009
down_shrink_days 1
breakout_level_20d 179.1
vcp_breakout_confirm false
contraction_ratio_10_30 0.2963
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.8
rsiKdjPoints 4
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 1
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 1.2

情緒分析 — 3/10 · 較差

Dimension score 3/10
Dimension grade 較差

Sub-items

sentiment

score 3

details

source finnhub_news_keyword_model
articleCount 5
negativeHits 0
positiveHits 1
sentimentScoreRaw 0.5

sentimentData

raw {"id":143022197,"url":"https://finnhub.io/api/news?id=3ad55fe22e10dbf442c563e643580ea7c6ecd728baf15eb322caeea0425aba95","image":"https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp","source":"ChartMill","related":"A","summary":"Agilent clears the Caviar Cruise quality screen with high ROIC, cash-backed profits, low debt, and forward growth, though valuation is a risk.","category":"company","datetime":1792497054,"headline":"Agilent Technologies (NYSE:A) Stands Out as a Quality Stock on Strong Returns and Cash Flow"}, {"id":142820200,"url":"https://finnhub.io/api/news?id=e5b5228a892afb854995ba185b865f6af7d31e47c95767cdc2d37e77e167926f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.","category":"company","datetime":1791808802,"headline":"Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?"}, {"id":142731215,"url":"https://finnhub.io/api/news?id=b9ad7f7c83f68f77f768b32672fe150f58440903e569bbc9921aca0b44bb676c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies has delivered a solid share price run over recent years, and the question now is whether the current valuation is properly backed by the cash the business can generate. With fresh investment in new labs and instruments on the table, investors are asking how those projects feed into the stock's intrinsic value based on its cash flows. Over the past 3 years the stock has returned 52.5%, which puts real weight on whether cash generation can support the price that move has...","category":"company","datetime":1791479981,"headline":"Is Agilent Technologies (A) Cheap Enough To Justify Its Cash Flow?"}, {"id":142633835,"url":"https://finnhub.io/api/news?id=2eb8408fc2372f0d7df88dbbc9133e3a1155d872cc69ffa7774a7678864fa389","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2276411485/image_2276411485.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"First Trust Water ETF keeps underperforming the broader market, implying that there's more to consider than just demand. I rate the FIW ETF as Sell. Click to read my analysis.","category":"company","datetime":1791185457,"headline":"FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A Buy"}, {"id":142445426,"url":"https://finnhub.io/api/news?id=9c786dfccd5c711947457a233c7a6a55226c5e0c02b2d5e54c9a5e36229e194e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...","category":"company","datetime":1790489579,"headline":"Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story"}
raw_source {"id":143234638,"url":"https://finnhub.io/api/news?id=33fd0469ae630f7ea9f3ae4002535a26eb02d001953c63688dc3ae3c0ee967b5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif. & CHICAGO, October 27, 2026--Agilent Technologies Inc. (NYSE: A), a global leader in analytical and clinical laboratory technologies, and the University of Chicago, one of the world’s leading research universities, today announced a scientific collaboration to establish the Agilent Center of Excellence (CoE) for Energy Materials Research.","category":"company","datetime":1793102400,"headline":"Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research"}, {"id":143210311,"url":"https://finnhub.io/api/news?id=62c9e537512e6cb978d648e347ec2aa3a50766d750d6f92ee0d52c2445aeb54f","image":"","source":"Fintel","related":"A","summary":"","category":"company","datetime":1793065761,"headline":"Deutsche Bank Initiates Coverage of Agilent Technologies at Buy"}, {"id":139762682,"url":"https://finnhub.io/api/news?id=36ec11a2c407b450f53c7d6f174dfeaa3ae2ddf57e85a2ecae63910222992539","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls","category":"company","datetime":1793022131,"headline":"Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls"}, {"id":143190207,"url":"https://finnhub.io/api/news?id=323c51ff55e42e4c75789b502cab9ae59fe8e5737e4acd79195dab1edd735b7a","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1484319196/image_1484319196.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Greenlight Capital questions the market valuations and TAM claims of AI providers in Q3 2026. Read the full analysis for more details.","category":"company","datetime":1792984200,"headline":"How Can Investors Have Confidence In The Terminal Value Of The Large AI Providers"}, {"id":143143733,"url":"https://finnhub.io/api/news?id=1bf25eff3f4e92d5e3da84b6ae1d3b3cef34fe9794d5c4985be63bc283f867aa","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Get a weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers, including dividend changes and key ex-dividend dates.","category":"company","datetime":1792793778,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week October 25"}, {"id":143136290,"url":"https://finnhub.io/api/news?id=324ee5b3a38ddfccd02201049082a470e6a07e75ff50bef2f94295ef71da456f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"For questions about this article or underlying research, email help@trefis.com.","category":"company","datetime":1792777012,"headline":"Should Illumina Stock Holders Look At Thermo Fisher Instead?"}, {"id":143103807,"url":"https://finnhub.io/api/news?id=5c21fa63cd35232d2c5c26ebbabd64de5cc15b4566bd5be00d4e058a6c9a0e26","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Quest Diagnostics beats Q3 earnings and revenue estimates, raises its 2026 outlook on strong testing demand and margin gains, yet shares dip in pre-market trading.","category":"company","datetime":1792689420,"headline":"DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market"}, {"id":143067518,"url":"https://finnhub.io/api/news?id=794e1cfd80211130a51f49c289e590f333c24975e2283abfa22c1d3c8c1ea221","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Abbott's Q3 earnings miss weighs on its stock despite double-digit revenue growth and expanding margins, while lower 2026 sales guidance raises concerns.","category":"company","datetime":1792585740,"headline":"ABT Stock Down Post Q3 Earnings Miss, Revenues Rise Y/Y, Margins Up"}, {"id":143053238,"url":"https://finnhub.io/api/news?id=b3240d35fc726ac96d2a46990b129fdd96cab575deeba691835f9ad5f7890c5d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- \"Bioconjugation Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global bioconjugation market is experiencing rapid growth, supported by expanding biologics research, increased development of antibody-based therapeutics, and rising demand for advanced diagnostic assays. The market is projected to grow from $6.12 billion in 2025 to $6.89 billion in 2026, representing a compound annual growth rate (CAGR) of 12.5%. Growth during","category":"company","datetime":1792570260,"headline":"Bioconjugation Market Report 2026: Global Size, Share, Trends and 2030 Forecast | Capitalize on Targeted Therapeutics | Thermo Fisher, Merck, Danaher, Lonza, and Agilent Lead the Industry"}, {"id":143028934,"url":"https://finnhub.io/api/news?id=42fb19fac55354e2499a0acbf2bc8308b27df6ce408c5e6156e04c9f73a7e9cc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"WAT's AI Link launch and Anthropic collaboration aim to automate LC-MS workflows, streamline lab operations and drive instrument demand.","category":"company","datetime":1792502400,"headline":"Waters Launches AI Link to Advance AI-Enabled LC-MS Workflows"}, {"id":143022197,"url":"https://finnhub.io/api/news?id=3ad55fe22e10dbf442c563e643580ea7c6ecd728baf15eb322caeea0425aba95","image":"https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp","source":"ChartMill","related":"A","summary":"Agilent clears the Caviar Cruise quality screen with high ROIC, cash-backed profits, low debt, and forward growth, though valuation is a risk.","category":"company","datetime":1792497054,"headline":"Agilent Technologies (NYSE:A) Stands Out as a Quality Stock on Strong Returns and Cash Flow"}, {"id":143008103,"url":"https://finnhub.io/api/news?id=6a0037dab5aeaac2a085732688934dea1356ae0238c2f50d89765d291f02fdd6","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_1.jpg?width=2048&height=1536","source":"Benzinga","related":"A","summary":"Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 1.17% on an annualized basis producing an average annual return of 14.8%. Currently, Agilent Technologies has a market capitalization","category":"company","datetime":1792406743,"headline":"$1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today"}, {"id":142962673,"url":"https://finnhub.io/api/news?id=dd52dba685ab595cdbabab40302073ceebfd41def3e89be68d2df27a6913cf58","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"After three decades climbing to the top of one of Wall Street's most powerful firms, a single executive held millions of shares in the company he had given his career to. Then came the week that changed everything.","category":"company","datetime":1792254678,"headline":"In 2008, After 34 Years Working For The Same Company, He Owned More Than 6 Million Shares Of Company Stock. Eight Months Later, The Company Was Bankrupt and The Shares Were Nearly Worthless. The Story Of Joe Gregory Holds An Important Lesson For Every Investor"}, {"id":142946380,"url":"https://finnhub.io/api/news?id=8fff397571c718c07e445c7fb238c74aa0e31d5c1fbf64085e069e8d4530064e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.","category":"company","datetime":1792159899,"headline":"1 Surging Healthcare Stock Worth Your Attention and 2 We Turn Down"}, {"id":142940598,"url":"https://finnhub.io/api/news?id=262b21b1adc1b71fef9fe843b9b682d06e5d7329d37b36a536b81ad53e181907","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Report Tracks Roche Diagnostics, Thermo Fisher, Illumina, Agilent and Guardant Health Among 132 Companies, With Forecasts by Assay Type, Technology, Customer and CountryDublin, Oct. 16, 2026 (GLOBE NEWSWIRE) -- \"Immuno-Oncology Diagnostics. Market Forecasts for Immuno-Oncology Diagnostics by Assay Type, Technology, Client, and Country with Executive/Consultant Guides 2026 to 2030 (4th Edition)\" has been added to ResearchAndMarkets.com's offering. The report highlights the continued expansion of","category":"company","datetime":1792143780,"headline":"Immuno-Oncology Diagnostics Market to Reach $11.1B by 2030 as Checkpoint Inhibitor and Cell Therapy Pipelines Drive Demand for Companion Tests"}, {"id":142880640,"url":"https://finnhub.io/api/news?id=f59fb84a1dddc2400f63f414be29dad3e7429ba4db920560f5af7615a7d1d9b4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"The transaction, which is expected to close in Agilent’s fiscal year 2027, follows its $950m acquisition of Biocare Medical in March 2026.","category":"company","datetime":1791976316,"headline":"Agilent acquires Proscia in deal worth up to $270m"}, {"id":142884529,"url":"https://finnhub.io/api/news?id=c5802bcda140f286c39d247fed77151eb14a83c236706ed9d72001d98e550db9","image":"https://cdn.benzinga.com/files/images/story/2026/10/14/Business-Mergers-And-Acquisitions-Concep.jpg?width=2048&height=1536","source":"Benzinga","related":"A","summary":"Agilent (A) to acquire Proscia for up to $270M to expand AI-powered digital pathology & diagnostic capabilities. Stock edges higher.","category":"company","datetime":1791969631,"headline":"Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist"}, {"id":142872383,"url":"https://finnhub.io/api/news?id=f787c7b9b42d55a03cd4a0b6dcda8b2030c5da929b0fc2afc9f13417433f89b2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Players: Metabolon, Bruker, Agilent, Thermo Fisher and Waters. Profiles cover products, services, market share, segments, trends, opportunities and regional presence.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- \"Metabolomics Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global metabolomics market is experiencing rapid expansion, driven by advances in biomarker discovery, personalized medicine, cancer research and analytical technologies. The market grew from $4.17 bil","category":"company","datetime":1791965160,"headline":"Global Metabolomics Market Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on 17.3% CAGR as Thermo Fisher, Bruker, Agilent, and Metabolon Accelerate AI Diagnostics"}, {"id":142885464,"url":"https://finnhub.io/api/news?id=ca55eb1d7732b96a5721dd224220baa4cbf255435598a2e7e851fcfae6a23d8d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.","category":"company","datetime":1791959378,"headline":"Agilent to buy Proscia for $240M"}, {"id":142849053,"url":"https://finnhub.io/api/news?id=6fc26925705f3d72cf48b269551fa1c08ea36bb23b3f1ba47d48926b51183b6e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif. & PHILADELPHIA, October 13, 2026--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones.","category":"company","datetime":1791892800,"headline":"Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence"}, {"id":142884530,"url":"https://finnhub.io/api/news?id=c1b0d7a8d698fe1997b21a865b7d9783823b5719b16985faf0da984950fc4655","image":"","source":"Benzinga","related":"A","summary":"TD Cowen analyst Dan Brennan maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $180 to $196.","category":"company","datetime":1791891562,"headline":"TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $196"}, {"id":142884531,"url":"https://finnhub.io/api/news?id=9b35f2007459e45e29c82c9aa6d0e52a64c4e923f02492cd7953b9ea18d2b71a","image":"","source":"Benzinga","related":"A","summary":"Morgan Stanley analyst Kallum Titchmarsh maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $175 to $190.","category":"company","datetime":1791891494,"headline":"Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $190"}, {"id":142839262,"url":"https://finnhub.io/api/news?id=d2236c8c28c291f8d06435628151897272438e2c76e2f409c8bed47f16e3d589","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Chromosomal Microarray Reflex Testing Global Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global chromosomal microarray reflex testing market is experiencing strong growth as healthcare providers increase their use of advanced genomic diagnostics for prenatal, postnatal, oncology, and rare disease applications. The market is projected to grow from $1.39 billion in 2025 to $1.51 billion in 2026, representing a compound ann","category":"company","datetime":1791878580,"headline":"Global Chromosomal Microarray Reflex Testing Market Report 2026-2030 | Capitalize on 9.1% CAGR as Thermo Fisher, LabCorp, Illumina, Agilent, and Natera Scale Precision Genomics"}, {"id":142820200,"url":"https://finnhub.io/api/news?id=e5b5228a892afb854995ba185b865f6af7d31e47c95767cdc2d37e77e167926f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.","category":"company","datetime":1791808802,"headline":"Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?"}, {"id":142731215,"url":"https://finnhub.io/api/news?id=b9ad7f7c83f68f77f768b32672fe150f58440903e569bbc9921aca0b44bb676c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies has delivered a solid share price run over recent years, and the question now is whether the current valuation is properly backed by the cash the business can generate. With fresh investment in new labs and instruments on the table, investors are asking how those projects feed into the stock's intrinsic value based on its cash flows. Over the past 3 years the stock has returned 52.5%, which puts real weight on whether cash generation can support the price that move has...","category":"company","datetime":1791479981,"headline":"Is Agilent Technologies (A) Cheap Enough To Justify Its Cash Flow?"}, {"id":142695688,"url":"https://finnhub.io/api/news?id=54b2461c864239e33dfabc7a5f3aa6a8062696dfa72aec15a19b4970dde3fecc","image":"","source":"Benzinga","related":"A","summary":"Barclays analyst Luke Sergott maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $175 to $195.","category":"company","datetime":1791365165,"headline":"Barclays Maintains Overweight on Agilent Technologies, Raises Price Target to $195"}, {"id":142647609,"url":"https://finnhub.io/api/news?id=c842fcc48355b415ae781153021086982bc5ef2315cf2c17223cf25039995173","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2163482326/image_2163482326.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Technology was the only sector to gain in September as mega-cap strength masked broad market weakness. Read more here.","category":"company","datetime":1791250200,"headline":"Moat Stocks Retreat As Market Breadth Narrows"}, {"id":142633835,"url":"https://finnhub.io/api/news?id=2eb8408fc2372f0d7df88dbbc9133e3a1155d872cc69ffa7774a7678864fa389","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2276411485/image_2276411485.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"First Trust Water ETF keeps underperforming the broader market, implying that there's more to consider than just demand. I rate the FIW ETF as Sell. Click to read my analysis.","category":"company","datetime":1791185457,"headline":"FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A Buy"}, {"id":142593872,"url":"https://finnhub.io/api/news?id=499bf9bb38b2e7b37ffd4baa210386aa2765fea7f5aabdb08f96d7dabdf7322d","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Track weekly dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend and pay dates. Read it here.","category":"company","datetime":1790965134,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week October 4"}, {"id":142559868,"url":"https://finnhub.io/api/news?id=8b175ceb5b7bff39983b76422ee597a0905fad70b8d2ff3eeb3a31a160e63ea4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1790865004,"headline":"Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report?"}, {"id":142588193,"url":"https://finnhub.io/api/news?id=309bd205640725159056e0eb9ab31f49a57990c5d5ed2d0ca8a7b06b3613fb67","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536","source":"Benzinga","related":"A","summary":"Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 14.43%. Currently, Agilent Technologies has a market capitalization","category":"company","datetime":1790858747,"headline":"$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today"}, {"id":142557959,"url":"https://finnhub.io/api/news?id=8a17cf1a74d2ef0a8e32e203d206f2395bdb550fe0f0e12abcf88e004c2922dc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif., October 01, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time","category":"company","datetime":1790856000,"headline":"Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows"}, {"id":142496160,"url":"https://finnhub.io/api/news?id=ef18193aa55d6b8032d176e715ec487656be230854007991936e0d42bbb488e7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif., September 29, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis.","category":"company","datetime":1790683200,"headline":"Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers"}, {"id":142463307,"url":"https://finnhub.io/api/news?id=2a2c59b622ef2cae5b0b5c0f8089761a5aa4c5cfac4ea08d75d8dc51e8bbe26b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 46.9% gain over the past six months, beating the S&P 500 by 25.5 percentage points.","category":"company","datetime":1790587116,"headline":"3 Healthcare Stocks That Fall Short"}, {"id":142445426,"url":"https://finnhub.io/api/news?id=9c786dfccd5c711947457a233c7a6a55226c5e0c02b2d5e54c9a5e36229e194e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...","category":"company","datetime":1790489579,"headline":"Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story"}
data_source finnhub_news_keyword_model
article_count 5
negative_hits 0
positive_hits 1
recomputed_at_score true
sentiment_score_raw 0.5
source_article_count 35
discarded_article_count 30
sentimentPoints 3

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.6 5/110 72% 3.6
資金流 11.6 20/110 58% 11.6
市場環境 7.4 15/110 49.33% 7.4
催化劑 2 20/110 10% 2
風險管理 6.8 10/110 68% 6.8
技術信號 22 30/110 73.33% 22
情緒分析 3 10/110 30% 3

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 7/50
ret_5d 0.0259
max_score 50
max_total 50
raw_total 7
vcp_bonus 0
vol_ratio 1.0637
ret_points 4
vol_points 2
range_ratio 1.0436
volat_points 0
day_range_pct 0.0285
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.6368
turnoverUsdM 406.8458
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.A
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 168.13

strength_details

ma_score 1.5
atr_score 2
rsi_score 3
macd_score 1.5
volume_score 2
market_adjustment 1
risk_reward_ratio 1.3
stop_loss_percent 5.3
take_profit_price 189.1978
target_multiplier 1.9
technical_strength 1.98
take_profit_percent 6.6
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2515
stopLossPercent 5.2735
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.6/5分
資金流分析總分: 11.6/20分
市場環境分析總分: 7.4/15分
催化劑分析: 2/20分
風險管理總分: 6.8/10分
技術信號分析總分: 22/30分
情緒分析: 3/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 85.71
atr
atr 4.68
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.64
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value 135.27
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.0207
kdj
d 63.66
j 74.45
k 67.25
rule Cursor_18.24 K/D cross
score 6
signal 強金叉
mfi
rule Cursor_18.24 MFI bands
level 平衡
score 6
value 57.85
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 6
trend 有流入
value 20186018
recentSlope 21971.8
previousSlope 108780
rsi
value 63.59
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 168.8795
position SAR喺價下
distancePct 4.85
previousTrend 上升
ma50
value 162.54
macd
macd 3.7826
trend 中性偏多
signal 4.0355
histogram -0.2529
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 172.0615
position 連續5日>VWAP
consecutiveAbove 6
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.06
score 6
avgVolume 2166916
currentVolume 2292218
derived
ma20 172.0855
ma50 162.54
prevClose 175.96
avgVolume10 2217092
avgVolume20 2166916
changePercent 0.87
avgVolumeForScore 2166916
ma_cross
ma20 172.0855
ma50 162.54
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 171.9625
prevMa50 161.9592
spreadPct 5.87
isVolumeBreakout false
bollinger
lower 165.9839
upper 178.1871
position 上半部
rsi_short
value 72.39
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.06

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.636768120076166,
        "turnoverUsdM": 406.84579574218003,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.A",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 168.13,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 3,
        "macd_score": 1.5,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.3,
      "stop_loss_percent": 5.3,
      "take_profit_price": 189.1978,
      "target_multiplier": 1.9,
      "technical_strength": 1.98,
      "take_profit_percent": 6.6
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.251532121794872,
    "stopLossPercent": 5.273536240152332,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 63.4,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 56.4,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 172.0855,
    "ma50": 162.54,
    "close": 177.49,
    "prevClose": 175.96,
    "avgVolume20": 2166916,
    "volumeRatio": 1.06,
    "changePercent": 0.87
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": 0.025894547381192012,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 1.0636767138670855,
      "ret_points": 4,
      "vol_points": 2,
      "range_ratio": 1.0436224246556207,
      "volat_points": 0,
      "day_range_pct": 0.028508742548383356,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 63.4,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 72,
        "contribution": 3.6
      },
      {
        "raw": 11.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 58,
        "contribution": 11.6
      },
      {
        "raw": 7.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 49.33,
        "contribution": 7.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 68,
        "contribution": 6.8
      },
      {
        "raw": 22,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 73.33,
        "contribution": 22
      },
      {
        "raw": 3,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 30,
        "contribution": 3
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 56.4,
    "details": [
      "基本面分析總分: 3.6/5分",
      "資金流分析總分: 11.6/20分",
      "市場環境分析總分: 7.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.8/10分",
      "技術信號分析總分: 22/30分",
      "情緒分析: 3/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.6,
      "資金流": 11.6,
      "市場環境": 7.4,
      "情緒分析": 3,
      "技術信號": 22,
      "風險管理": 6.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0.6,
          "turnoverUsdM": 406.84579574218003,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 2.4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.A",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.39
            }
          },
          "trend": {
            "score": 1.7999999999999998,
            "details": {
              "qqq": {
                "ma20": 733.18400235,
                "ma50": 725.2621992000002,
                "name": "QQQ",
                "close": 721.23999,
                "points": 0.4
              },
              "spy": {
                "ma20": 770.4114959000001,
                "ma50": 767.5287948999999,
                "name": "SPY",
                "close": 769.65997,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.636768120076166,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 1.7999999999999998
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 3,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.5
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 143022197,
                "url": "https://finnhub.io/api/news?id=3ad55fe22e10dbf442c563e643580ea7c6ecd728baf15eb322caeea0425aba95",
                "image": "https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp",
                "source": "ChartMill",
                "related": "A",
                "summary": "Agilent clears the Caviar Cruise quality screen with high ROIC, cash-backed profits, low debt, and forward growth, though valuation is a risk.",
                "category": "company",
                "datetime": 1792497054,
                "headline": "Agilent Technologies (NYSE:A) Stands Out as a Quality Stock on Strong Returns and Cash Flow"
              },
              {
                "id": 142820200,
                "url": "https://finnhub.io/api/news?id=e5b5228a892afb854995ba185b865f6af7d31e47c95767cdc2d37e77e167926f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1791808802,
                "headline": "Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?"
              },
              {
                "id": 142731215,
                "url": "https://finnhub.io/api/news?id=b9ad7f7c83f68f77f768b32672fe150f58440903e569bbc9921aca0b44bb676c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies has delivered a solid share price run over recent years, and the question now is whether the current valuation is properly backed by the cash the business can generate. With fresh investment in new labs and instruments on the table, investors are asking how those projects feed into the stock's intrinsic value based on its cash flows. Over the past 3 years the stock has returned 52.5%, which puts real weight on whether cash generation can support the price that move has...",
                "category": "company",
                "datetime": 1791479981,
                "headline": "Is Agilent Technologies (A) Cheap Enough To Justify Its Cash Flow?"
              },
              {
                "id": 142633835,
                "url": "https://finnhub.io/api/news?id=2eb8408fc2372f0d7df88dbbc9133e3a1155d872cc69ffa7774a7678864fa389",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2276411485/image_2276411485.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "First Trust Water ETF keeps underperforming the broader market, implying that there's more to consider than just demand. I rate the FIW ETF as Sell. Click to read my analysis.",
                "category": "company",
                "datetime": 1791185457,
                "headline": "FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A Buy"
              },
              {
                "id": 142445426,
                "url": "https://finnhub.io/api/news?id=9c786dfccd5c711947457a233c7a6a55226c5e0c02b2d5e54c9a5e36229e194e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...",
                "category": "company",
                "datetime": 1790489579,
                "headline": "Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story"
              }
            ],
            "raw_source": [
              {
                "id": 143234638,
                "url": "https://finnhub.io/api/news?id=33fd0469ae630f7ea9f3ae4002535a26eb02d001953c63688dc3ae3c0ee967b5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif. & CHICAGO, October 27, 2026--Agilent Technologies Inc. (NYSE: A), a global leader in analytical and clinical laboratory technologies, and the University of Chicago, one of the world’s leading research universities, today announced a scientific collaboration to establish the Agilent Center of Excellence (CoE) for Energy Materials Research.",
                "category": "company",
                "datetime": 1793102400,
                "headline": "Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research"
              },
              {
                "id": 143210311,
                "url": "https://finnhub.io/api/news?id=62c9e537512e6cb978d648e347ec2aa3a50766d750d6f92ee0d52c2445aeb54f",
                "image": "",
                "source": "Fintel",
                "related": "A",
                "summary": "",
                "category": "company",
                "datetime": 1793065761,
                "headline": "Deutsche Bank Initiates Coverage of Agilent Technologies at Buy"
              },
              {
                "id": 139762682,
                "url": "https://finnhub.io/api/news?id=36ec11a2c407b450f53c7d6f174dfeaa3ae2ddf57e85a2ecae63910222992539",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1793022131,
                "headline": "Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls"
              },
              {
                "id": 143190207,
                "url": "https://finnhub.io/api/news?id=323c51ff55e42e4c75789b502cab9ae59fe8e5737e4acd79195dab1edd735b7a",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1484319196/image_1484319196.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Greenlight Capital questions the market valuations and TAM claims of AI providers in Q3 2026. Read the full analysis for more details.",
                "category": "company",
                "datetime": 1792984200,
                "headline": "How Can Investors Have Confidence In The Terminal Value Of The Large AI Providers"
              },
              {
                "id": 143143733,
                "url": "https://finnhub.io/api/news?id=1bf25eff3f4e92d5e3da84b6ae1d3b3cef34fe9794d5c4985be63bc283f867aa",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Get a weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers, including dividend changes and key ex-dividend dates.",
                "category": "company",
                "datetime": 1792793778,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week October 25"
              },
              {
                "id": 143136290,
                "url": "https://finnhub.io/api/news?id=324ee5b3a38ddfccd02201049082a470e6a07e75ff50bef2f94295ef71da456f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "For questions about this article or underlying research, email help@trefis.com.",
                "category": "company",
                "datetime": 1792777012,
                "headline": "Should Illumina Stock Holders Look At Thermo Fisher Instead?"
              },
              {
                "id": 143103807,
                "url": "https://finnhub.io/api/news?id=5c21fa63cd35232d2c5c26ebbabd64de5cc15b4566bd5be00d4e058a6c9a0e26",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Quest Diagnostics beats Q3 earnings and revenue estimates, raises its 2026 outlook on strong testing demand and margin gains, yet shares dip in pre-market trading.",
                "category": "company",
                "datetime": 1792689420,
                "headline": "DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market"
              },
              {
                "id": 143067518,
                "url": "https://finnhub.io/api/news?id=794e1cfd80211130a51f49c289e590f333c24975e2283abfa22c1d3c8c1ea221",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Abbott's Q3 earnings miss weighs on its stock despite double-digit revenue growth and expanding margins, while lower 2026 sales guidance raises concerns.",
                "category": "company",
                "datetime": 1792585740,
                "headline": "ABT Stock Down Post Q3 Earnings Miss, Revenues Rise Y/Y, Margins Up"
              },
              {
                "id": 143053238,
                "url": "https://finnhub.io/api/news?id=b3240d35fc726ac96d2a46990b129fdd96cab575deeba691835f9ad5f7890c5d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- \"Bioconjugation Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global bioconjugation market is experiencing rapid growth, supported by expanding biologics research, increased development of antibody-based therapeutics, and rising demand for advanced diagnostic assays. The market is projected to grow from $6.12 billion in 2025 to $6.89 billion in 2026, representing a compound annual growth rate (CAGR) of 12.5%. Growth during",
                "category": "company",
                "datetime": 1792570260,
                "headline": "Bioconjugation Market Report 2026: Global Size, Share, Trends and 2030 Forecast | Capitalize on Targeted Therapeutics | Thermo Fisher, Merck, Danaher, Lonza, and Agilent Lead the Industry"
              },
              {
                "id": 143028934,
                "url": "https://finnhub.io/api/news?id=42fb19fac55354e2499a0acbf2bc8308b27df6ce408c5e6156e04c9f73a7e9cc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "WAT's AI Link launch and Anthropic collaboration aim to automate LC-MS workflows, streamline lab operations and drive instrument demand.",
                "category": "company",
                "datetime": 1792502400,
                "headline": "Waters Launches AI Link to Advance AI-Enabled LC-MS Workflows"
              },
              {
                "id": 143022197,
                "url": "https://finnhub.io/api/news?id=3ad55fe22e10dbf442c563e643580ea7c6ecd728baf15eb322caeea0425aba95",
                "image": "https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp",
                "source": "ChartMill",
                "related": "A",
                "summary": "Agilent clears the Caviar Cruise quality screen with high ROIC, cash-backed profits, low debt, and forward growth, though valuation is a risk.",
                "category": "company",
                "datetime": 1792497054,
                "headline": "Agilent Technologies (NYSE:A) Stands Out as a Quality Stock on Strong Returns and Cash Flow"
              },
              {
                "id": 143008103,
                "url": "https://finnhub.io/api/news?id=6a0037dab5aeaac2a085732688934dea1356ae0238c2f50d89765d291f02fdd6",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "A",
                "summary": "Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 1.17% on an annualized basis producing an average annual return of 14.8%. Currently, Agilent Technologies has a market capitalization",
                "category": "company",
                "datetime": 1792406743,
                "headline": "$1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today"
              },
              {
                "id": 142962673,
                "url": "https://finnhub.io/api/news?id=dd52dba685ab595cdbabab40302073ceebfd41def3e89be68d2df27a6913cf58",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "After three decades climbing to the top of one of Wall Street's most powerful firms, a single executive held millions of shares in the company he had given his career to. Then came the week that changed everything.",
                "category": "company",
                "datetime": 1792254678,
                "headline": "In 2008, After 34 Years Working For The Same Company, He Owned More Than 6 Million Shares Of Company Stock. Eight Months Later, The Company Was Bankrupt and The Shares Were Nearly Worthless. The Story Of Joe Gregory Holds An Important Lesson For Every Investor"
              },
              {
                "id": 142946380,
                "url": "https://finnhub.io/api/news?id=8fff397571c718c07e445c7fb238c74aa0e31d5c1fbf64085e069e8d4530064e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.",
                "category": "company",
                "datetime": 1792159899,
                "headline": "1 Surging Healthcare Stock Worth Your Attention and 2 We Turn Down"
              },
              {
                "id": 142940598,
                "url": "https://finnhub.io/api/news?id=262b21b1adc1b71fef9fe843b9b682d06e5d7329d37b36a536b81ad53e181907",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Report Tracks Roche Diagnostics, Thermo Fisher, Illumina, Agilent and Guardant Health Among 132 Companies, With Forecasts by Assay Type, Technology, Customer and CountryDublin, Oct. 16, 2026 (GLOBE NEWSWIRE) -- \"Immuno-Oncology Diagnostics. Market Forecasts for Immuno-Oncology Diagnostics by Assay Type, Technology, Client, and Country with Executive/Consultant Guides 2026 to 2030 (4th Edition)\" has been added to ResearchAndMarkets.com's offering. The report highlights the continued expansion of",
                "category": "company",
                "datetime": 1792143780,
                "headline": "Immuno-Oncology Diagnostics Market to Reach $11.1B by 2030 as Checkpoint Inhibitor and Cell Therapy Pipelines Drive Demand for Companion Tests"
              },
              {
                "id": 142880640,
                "url": "https://finnhub.io/api/news?id=f59fb84a1dddc2400f63f414be29dad3e7429ba4db920560f5af7615a7d1d9b4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "The transaction, which is expected to close in Agilent’s fiscal year 2027, follows its $950m acquisition of Biocare Medical in March 2026.",
                "category": "company",
                "datetime": 1791976316,
                "headline": "Agilent acquires Proscia in deal worth up to $270m"
              },
              {
                "id": 142884529,
                "url": "https://finnhub.io/api/news?id=c5802bcda140f286c39d247fed77151eb14a83c236706ed9d72001d98e550db9",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/14/Business-Mergers-And-Acquisitions-Concep.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "A",
                "summary": "Agilent (A) to acquire Proscia for up to $270M to expand AI-powered digital pathology & diagnostic capabilities. Stock edges higher.",
                "category": "company",
                "datetime": 1791969631,
                "headline": "Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist"
              },
              {
                "id": 142872383,
                "url": "https://finnhub.io/api/news?id=f787c7b9b42d55a03cd4a0b6dcda8b2030c5da929b0fc2afc9f13417433f89b2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Players: Metabolon, Bruker, Agilent, Thermo Fisher and Waters. Profiles cover products, services, market share, segments, trends, opportunities and regional presence.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- \"Metabolomics Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global metabolomics market is experiencing rapid expansion, driven by advances in biomarker discovery, personalized medicine, cancer research and analytical technologies. The market grew from $4.17 bil",
                "category": "company",
                "datetime": 1791965160,
                "headline": "Global Metabolomics Market Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on 17.3% CAGR as Thermo Fisher, Bruker, Agilent, and Metabolon Accelerate AI Diagnostics"
              },
              {
                "id": 142885464,
                "url": "https://finnhub.io/api/news?id=ca55eb1d7732b96a5721dd224220baa4cbf255435598a2e7e851fcfae6a23d8d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.",
                "category": "company",
                "datetime": 1791959378,
                "headline": "Agilent to buy Proscia for $240M"
              },
              {
                "id": 142849053,
                "url": "https://finnhub.io/api/news?id=6fc26925705f3d72cf48b269551fa1c08ea36bb23b3f1ba47d48926b51183b6e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif. & PHILADELPHIA, October 13, 2026--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones.",
                "category": "company",
                "datetime": 1791892800,
                "headline": "Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence"
              },
              {
                "id": 142884530,
                "url": "https://finnhub.io/api/news?id=c1b0d7a8d698fe1997b21a865b7d9783823b5719b16985faf0da984950fc4655",
                "image": "",
                "source": "Benzinga",
                "related": "A",
                "summary": "TD Cowen  analyst Dan Brennan   maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $180 to $196.",
                "category": "company",
                "datetime": 1791891562,
                "headline": "TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $196"
              },
              {
                "id": 142884531,
                "url": "https://finnhub.io/api/news?id=9b35f2007459e45e29c82c9aa6d0e52a64c4e923f02492cd7953b9ea18d2b71a",
                "image": "",
                "source": "Benzinga",
                "related": "A",
                "summary": "Morgan Stanley  analyst Kallum Titchmarsh   maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $175 to $190.",
                "category": "company",
                "datetime": 1791891494,
                "headline": "Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $190"
              },
              {
                "id": 142839262,
                "url": "https://finnhub.io/api/news?id=d2236c8c28c291f8d06435628151897272438e2c76e2f409c8bed47f16e3d589",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Chromosomal Microarray Reflex Testing Global Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global chromosomal microarray reflex testing market is experiencing strong growth as healthcare providers increase their use of advanced genomic diagnostics for prenatal, postnatal, oncology, and rare disease applications. The market is projected to grow from $1.39 billion in 2025 to $1.51 billion in 2026, representing a compound ann",
                "category": "company",
                "datetime": 1791878580,
                "headline": "Global Chromosomal Microarray Reflex Testing Market Report 2026-2030 | Capitalize on 9.1% CAGR as Thermo Fisher, LabCorp, Illumina, Agilent, and Natera Scale Precision Genomics"
              },
              {
                "id": 142820200,
                "url": "https://finnhub.io/api/news?id=e5b5228a892afb854995ba185b865f6af7d31e47c95767cdc2d37e77e167926f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1791808802,
                "headline": "Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?"
              },
              {
                "id": 142731215,
                "url": "https://finnhub.io/api/news?id=b9ad7f7c83f68f77f768b32672fe150f58440903e569bbc9921aca0b44bb676c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies has delivered a solid share price run over recent years, and the question now is whether the current valuation is properly backed by the cash the business can generate. With fresh investment in new labs and instruments on the table, investors are asking how those projects feed into the stock's intrinsic value based on its cash flows. Over the past 3 years the stock has returned 52.5%, which puts real weight on whether cash generation can support the price that move has...",
                "category": "company",
                "datetime": 1791479981,
                "headline": "Is Agilent Technologies (A) Cheap Enough To Justify Its Cash Flow?"
              },
              {
                "id": 142695688,
                "url": "https://finnhub.io/api/news?id=54b2461c864239e33dfabc7a5f3aa6a8062696dfa72aec15a19b4970dde3fecc",
                "image": "",
                "source": "Benzinga",
                "related": "A",
                "summary": "Barclays  analyst Luke Sergott   maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $175 to $195.",
                "category": "company",
                "datetime": 1791365165,
                "headline": "Barclays Maintains Overweight on Agilent Technologies, Raises Price Target to $195"
              },
              {
                "id": 142647609,
                "url": "https://finnhub.io/api/news?id=c842fcc48355b415ae781153021086982bc5ef2315cf2c17223cf25039995173",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2163482326/image_2163482326.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Technology was the only sector to gain in September as mega-cap strength masked broad market weakness. Read more here.",
                "category": "company",
                "datetime": 1791250200,
                "headline": "Moat Stocks Retreat As Market Breadth Narrows"
              },
              {
                "id": 142633835,
                "url": "https://finnhub.io/api/news?id=2eb8408fc2372f0d7df88dbbc9133e3a1155d872cc69ffa7774a7678864fa389",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2276411485/image_2276411485.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "First Trust Water ETF keeps underperforming the broader market, implying that there's more to consider than just demand. I rate the FIW ETF as Sell. Click to read my analysis.",
                "category": "company",
                "datetime": 1791185457,
                "headline": "FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A Buy"
              },
              {
                "id": 142593872,
                "url": "https://finnhub.io/api/news?id=499bf9bb38b2e7b37ffd4baa210386aa2765fea7f5aabdb08f96d7dabdf7322d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Track weekly dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend and pay dates. Read it here.",
                "category": "company",
                "datetime": 1790965134,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week October 4"
              },
              {
                "id": 142559868,
                "url": "https://finnhub.io/api/news?id=8b175ceb5b7bff39983b76422ee597a0905fad70b8d2ff3eeb3a31a160e63ea4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1790865004,
                "headline": "Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report?"
              },
              {
                "id": 142588193,
                "url": "https://finnhub.io/api/news?id=309bd205640725159056e0eb9ab31f49a57990c5d5ed2d0ca8a7b06b3613fb67",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "A",
                "summary": "Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 14.43%. Currently, Agilent Technologies has a market capitalization",
                "category": "company",
                "datetime": 1790858747,
                "headline": "$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today"
              },
              {
                "id": 142557959,
                "url": "https://finnhub.io/api/news?id=8a17cf1a74d2ef0a8e32e203d206f2395bdb550fe0f0e12abcf88e004c2922dc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif., October 01, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time",
                "category": "company",
                "datetime": 1790856000,
                "headline": "Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows"
              },
              {
                "id": 142496160,
                "url": "https://finnhub.io/api/news?id=ef18193aa55d6b8032d176e715ec487656be230854007991936e0d42bbb488e7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif., September 29, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis.",
                "category": "company",
                "datetime": 1790683200,
                "headline": "Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers"
              },
              {
                "id": 142463307,
                "url": "https://finnhub.io/api/news?id=2a2c59b622ef2cae5b0b5c0f8089761a5aa4c5cfac4ea08d75d8dc51e8bbe26b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 46.9% gain over the past six months, beating the S&P 500 by 25.5 percentage points.",
                "category": "company",
                "datetime": 1790587116,
                "headline": "3 Healthcare Stocks That Fall Short"
              },
              {
                "id": 142445426,
                "url": "https://finnhub.io/api/news?id=9c786dfccd5c711947457a233c7a6a55226c5e0c02b2d5e54c9a5e36229e194e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...",
                "category": "company",
                "datetime": 1790489579,
                "headline": "Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 5,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.5,
            "source_article_count": 35,
            "discarded_article_count": 30
          },
          "sentimentPoints": 3
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 22,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1.6,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.6,
            "vcp_reason": "波幅收縮(18.1%→5.4%);站上MA50;Ready=N;Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 2419750,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 2141540,
              "avg_vol_20": 2154995,
              "avg_vol_30": 2419750,
              "range_pct_10": 0.05358053672992634,
              "range_pct_20": 0.08890641225385024,
              "range_pct_30": 0.1808553056028336,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": false,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8850253125322864,
              "dist_to_20d_high": 0.008989390899531415,
              "down_shrink_days": 1,
              "breakout_level_20d": 179.10001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.29626190147604303
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.636768120076166,
              "turnoverUsdM": 406.84579574218003,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.A",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 168.13,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 3,
              "macd_score": 1.5,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.3,
            "stop_loss_percent": 5.3,
            "take_profit_price": 189.1978,
            "target_multiplier": 1.9,
            "technical_strength": 1.98,
            "take_profit_percent": 6.6
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.251532121794872,
          "stopLossPercent": 5.273536240152332,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 4.68,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.64
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 135.27
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0207
    },
    "kdj": {
      "d": 63.66,
      "j": 74.45,
      "k": 67.25,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 57.85
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 6,
      "trend": "有流入",
      "value": 20186018,
      "recentSlope": 21971.8,
      "previousSlope": 108780
    },
    "rsi": 63.59,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 168.8795,
      "position": "SAR喺價下",
      "distancePct": 4.85,
      "previousTrend": "上升"
    },
    "ma50": 162.54,
    "macd": {
      "macd": 3.7826201211356647,
      "trend": "中性偏多",
      "signal": 4.035522028288078,
      "histogram": -0.25290190715241323
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 172.0615,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 6
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.06,
      "score": 6,
      "avgVolume": 2166916,
      "currentVolume": 2292218
    },
    "derived": {
      "ma20": 172.0855,
      "ma50": 162.54,
      "prevClose": 175.96,
      "avgVolume10": 2217092,
      "avgVolume20": 2166916,
      "changePercent": 0.87,
      "avgVolumeForScore": 2166916
    },
    "ma_cross": {
      "ma20": 172.0855,
      "ma50": 162.54,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 171.9625,
      "prevMa50": 161.9592,
      "spreadPct": 5.87,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 165.9839,
      "upper": 178.1871,
      "position": "上半部"
    },
    "rsi_short": 72.39,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.06
    }
  }
}

Raw metrics JSON

{
  "close": 177.49,
  "volume": 2292218,
  "changePercent": 0.87
}

Scores are derived from cached daily market data using the Solorank 110-point standard. Solorank provides research support only and does not provide financial advice or buy/sell recommendations.